Premenstrual disorders linked to higher suicide risk in women

Publicly released:
International
Photo by Sara Rolin on Unsplash
Photo by Sara Rolin on Unsplash

***This media release contains information some readers may find distressing as it refers to data about mental health, suicide and self-harm. If you or anyone you know needs help, support is available now. Call Lifeline (Aus) on 131 114 or Beyond Blue on 1300 22 4636, or Lifeline (NZ) on 0800 543 354. ***

Women diagnosed with serious mental or physical symptoms ahead of their periods have a higher risk of dying by suicide, according to a Swedish study. The researchers looked at death data among a group of nearly 70,000 women with a diagnosed premenstrual disorder and compared it to over 300,000 unaffected women of similar demographics. Looking for differences in deaths after an average of six years, the researchers say there were no differences in the rate of dying prematurely from any cause, however, there was an increased risk of death by suicide among the women with premenstrual disorders, and a higher risk of death by any cause among women who were diagnosed before age 25 that the researchers say is not entirely explained by the heightened suicide risk.

News release

From: JAMA

About The Study: The findings of this matched cohort study suggest that women with premenstrual disorders are not at increased risk of early death overall. However, the risk was elevated among young women and for death by suicide. This supports the importance of careful follow-up for young patients and highlights the need to develop suicide prevention strategies for all women with premenstrual disorders.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Network Open
Research:Paper
Organisation/s: Karolinska Institutet, Sweden
Funder: Thisworkwas supported by the Swedish Research Council for Health,Working Life andWelfare (FORTE) (grant No. 2020-00971 to Dr Lu), the Swedish Research Council (Vetenskapsrådet) (grant No. 2020- 01003 to Dr Lu), the Karolinska Institutet Strategic Research Area in Epidemiology and Biostatistics (to Dr Lu), the Icelandic Research Fund (grant No. 218274-051 to Dr Valdimarsdóttir), and the Mental Health Foundation (Fonden för Psykisk Hälsa, to Dr Opatowski).
Media Contact/s
Contact details are only visible to registered journalists.